353 related articles for article (PubMed ID: 24398140)
1. Acute aseptic meningitis as the initial presentation of a macroprolactinoma.
Boscolo M; Baleriaux D; Bakoto N; Corvilain B; Devuyst F
BMC Res Notes; 2014 Jan; 7():9. PubMed ID: 24398140
[TBL] [Abstract][Full Text] [Related]
2. Ectopic Prolactinoma Presenting as Bacterial Meningitis: A Diagnostic Conundrum.
Akinduro OO; Akinduro OT; Gupta V; Reimer R; Olomu O
World Neurosurg; 2018 Apr; 112():227-231. PubMed ID: 29378345
[TBL] [Abstract][Full Text] [Related]
3. [Pituitary apoplexy in a pregnant woman with cystic microprolactinoma].
Querol Ripoll R; Cámara Gómez R; Del Olmo García M; Simal Julián JA; Merino Torres JF
Endocrinol Nutr; 2015 Apr; 62(4):200-2. PubMed ID: 25732323
[No Abstract] [Full Text] [Related]
4. Meningitis as a presentation of macroprolactinoma.
Honegger J; Psaras T; Petrick M; Reincke M
Exp Clin Endocrinol Diabetes; 2009 Jul; 117(7):361-4. PubMed ID: 19591087
[TBL] [Abstract][Full Text] [Related]
5. Treatment Strategy for Giant Invasive Macroprolactinoma with Spontaneous Cerebrospinal Fluid Rhinorrhea: A Case Report and Literature Review.
Abe D; Ogiwara T; Nakamura T; Ichinose S; Fujii Y; Hanaoka Y; Ito K; Horiuchi T
World Neurosurg; 2020 Dec; 144():19-23. PubMed ID: 32853764
[TBL] [Abstract][Full Text] [Related]
6. What causes a prolactinoma to be aggressive or to become a pituitary carcinoma?
Phillips J; East HE; French SE; Melcescu E; Hamilton RD; Nicholas WC; Fratkin JF; Parent AD; Luzardo G; Koch CA
Hormones (Athens); 2012; 11(4):477-82. PubMed ID: 23422771
[TBL] [Abstract][Full Text] [Related]
7. Chronic anemia as first clinical manifestation of a prolactin-secreting pituitary macroadenoma in a male patient.
Iglesias P; Díez JJ
Am J Med; 2011 Jun; 124(6):e3-4. PubMed ID: 21605718
[No Abstract] [Full Text] [Related]
8. Falsely low serum prolactin in two cases of invasive macroprolactinoma.
Schöfl C; Schöfl-Siegert B; Karstens JH; Bremer M; Lenarz T; Cuarezma JS; Samii M; von zur Mühlen A; Brabant G
Pituitary; 2002; 5(4):261-5. PubMed ID: 14558675
[TBL] [Abstract][Full Text] [Related]
9. CSF rhinorrhoea following treatment with dopamine agonists for massive invasive prolactinomas.
Leong KS; Foy PM; Swift AC; Atkin SL; Hadden DR; MacFarlane IA
Clin Endocrinol (Oxf); 2000 Jan; 52(1):43-9. PubMed ID: 10651752
[TBL] [Abstract][Full Text] [Related]
10. Misdiagnosis due to the hook effect in prolactin assay.
Yener S; Comlekci A; Arda N; Men S; Yesil S
Med Princ Pract; 2008; 17(5):429-31. PubMed ID: 18685288
[TBL] [Abstract][Full Text] [Related]
11. Cabergoline-induced CSF rhinorrhea in patients with macroprolactinoma. Report of three cases.
Cappabianca P; Lodrini S; Felisati G; Peca C; Cozzi R; Di Sarno A; Cavallo LM; Giombini S; Colao A
J Endocrinol Invest; 2001 Mar; 24(3):183-7. PubMed ID: 11314748
[TBL] [Abstract][Full Text] [Related]
12. Cerebrospinal fluid rhinorrhea associated with untreated prolactinoma--case report.
Ohtakara K; Matsubara T; Kojima T; Taki W; Waga S
Neurol Med Chir (Tokyo); 2000 Aug; 40(8):413-8. PubMed ID: 10979264
[TBL] [Abstract][Full Text] [Related]
13. Spontaneous cerebrospinal fluid rhinorrhea in untreated macroprolactinoma--an indication for primary surgical therapy.
Honegger JB; Psaras T; Petrick M; Beuschlein F; Reincke M
Zentralbl Neurochir; 2006 Aug; 67(3):149-54. PubMed ID: 16958013
[TBL] [Abstract][Full Text] [Related]
14. Prolactinomas in children and adolescents.
Colao A; Loche S
Endocr Dev; 2010; 17():146-159. PubMed ID: 19955764
[TBL] [Abstract][Full Text] [Related]
15. The assessment of cabergoline efficacy and tolerability in patients with pituitary prolactinoma type.
Bolko P; Jaskuła M; Waśko R; Wołuń M; Sowiński J
Pol Arch Med Wewn; 2003 May; 109(5):489-95. PubMed ID: 14768178
[TBL] [Abstract][Full Text] [Related]
16. A giant prolactinoma presenting with unilateral exophthalmos: effect of cabergoline and review of the literature.
Berwaerts J; Verhelst J; Abs R; Appel B; Mahler C
J Endocrinol Invest; 2000 Jun; 23(6):393-8. PubMed ID: 10908167
[TBL] [Abstract][Full Text] [Related]
17. Cerebrospinal meningitis in a 30 -year -old patient as first manifestation of pituitary macroadenoma.
Andrysiak -Mamos E; Żochowska E; Kaźmierczyk -Puchalska A; Sagan L; Sowińska -Przepiera E; Zając -Marczewska M; Kojder I; Syrenicz A
Pomeranian J Life Sci; 2015; 61(4):403-10. PubMed ID: 29522662
[TBL] [Abstract][Full Text] [Related]
18. Ten-year follow-up of a giant prolactinoma.
Fernandes V; Santos MJ; Almeida R; Marques O
BMJ Case Rep; 2015 Nov; 2015():. PubMed ID: 26590188
[TBL] [Abstract][Full Text] [Related]
19. Multiple Endocrine Neoplasia Type 1 (MEN1) Presenting as an Invasive Macroprolactinoma Complicated by Acute Bacterial Meningitis.
Bandaru S; Jaju A; Manthri S; Mamillapalli C; Jakoby MG
Cureus; 2021 Dec; 13(12):e20086. PubMed ID: 34993034
[TBL] [Abstract][Full Text] [Related]
20. Recovery of growth hormone secretion following cabergoline treatment of macroprolactinomas.
George LD; Nicolau N; Scanlon MF; Davies JS
Clin Endocrinol (Oxf); 2000 Nov; 53(5):595-9. PubMed ID: 11106920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
